Status:

COMPLETED

Efficacy of Influenza Vaccine in HIV Infected Adults

Lead Sponsor:

University of Witwatersrand, South Africa

Conditions:

HIV

Influenza

Eligibility:

All Genders

18-55 years

Phase:

PHASE4

Brief Summary

Vaccination of HIV infected individuals with the sub-unit influenza vaccine is safe; however it induces only moderate immune responses and likewise is modest in its protection compared to HIV uninfect...

Eligibility Criteria

Inclusion

  • HIV infected adult on stable first line HAART for more than 3 months or anti-retroviral naïve HIV infected adult with a CD4+ cell count \>100 cells/ml performed within the previous 3 months in relation to the date of randomization.
  • Age 18-55 years.
  • Willing and able to maintain weekly contact at least during period of April - August (i.e. presupposed influenza period) either through SMS or telephonic contact.
  • Willing and able to adhere to study protocol re: attendance to clinic for scheduled and illness visits.

Exclusion

  • Any contraindication to influenza vaccination, including known allergy to egg.
  • Currently on treatment for tuberculosis or received treatment for tuberculosis in the past 6 months.
  • History of chronic lung disease which required maintenance therapy either currently or in the past 6 months.
  • Any contraindication to intramuscular injections.
  • Current known grade 3 or grade 4 laboratory or clinical toxicity as per DAIDS toxicity tables.
  • Any previous history of influenza or pneumococcal vaccination.
  • Any plan to vaccinate against influenza or pneumococcal disease during the course of the study.
  • Plan to emigrate from the study area within the next year.
  • On steroid therapy for \>21 days (current or within the past 30 days).
  • In the investigators opinion unable to maintain study procedures.

Key Trial Info

Start Date :

April 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

507 Patients enrolled

Trial Details

Trial ID

NCT00757900

Start Date

April 1 2008

End Date

September 1 2008

Last Update

October 9 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Helen Joseph Hospital

Johannesburg, Gauteng, South Africa